Remove Doctors Remove Fraud Remove Governance Remove Prescription Drug Pricing
article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

Health Provider News – July 22, 2022

Hall Render

cancer, cardio lab fraud. Doctors: Kentucky hospitals have enough room amidst summertime COVID-19 surge. Rising prescription drug prices contributed to 49% jump in Oregon healthcare costs over 6-year period: report. US government suit against UPMC and star surgeon moves forward. HHS orders additional 2.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

in billing fraud Arizona system names new CEO Banner Health CEO Peter Fine to retire after 24 years, handing the reins to health system president Four UArizona bioscience startups selected for Flinn Foundation program Gov. What it’s saying — and not saying When Saltzer Health closed, these 5 doctors’ patients needed care.

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

CMS overhauls Direct Contracting model to include new requirements on governance, health equity in 2023. Georgia Doctors and Public Health Officials Discuss Combating COVID-19. Whitmer signs bills designed to lower prescription drug prices in Michigan. Trial underway for Ohio doctor charged in hospital deaths.

article thumbnail

Health Provider News

Hall Render

Children’s mental health programs in danger after budget cuts Disciplinary information is missing from some doctor profiles in CT. Petersburg Cano Health board members re-elected despite opposition from billionaire Cano Health CEO Marlow Hernandez steps down Flagler-UF Health merger agreement expected to be signed Sept. too much.

article thumbnail

Guest Post – Second Circuit Rejects Manufacturer’s Plan to Share Cost of Expensive Drug with Medicare Part D Beneficiaries

Drug & Device Law

In Ruan , the Supreme Court examined the case of two doctors who were convicted of violating the Controlled Substances Act (“CSA”), 21 U.S.C. § 2022) (presuming that commission based compensation violates the AKS, while affirming dismissal for failure to plead fraud with the requisite particularity); United States v. Nicholson v.